Article Information
History
- November 11, 2019.
Article Versions
- Version 1 (July 9, 2019 - 12:58).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michael N Weedon, associate professor1,*,
- Leigh Jackson, lecturer1,*,
- James W Harrison, postdoctoral researcher1,
- Kate S Ruth, postdoctoral researcher1,
- Jessica Tyrrell, senior lecturer1,
- Andrew T Hattersley, professor and consultant diabetologist1 and
- Caroline F Wright, senior lecturer1,$
- 1Institute of Biomedical and Clinical Science, University of Exeter College of Medicine and Health, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter UK, EX2 5DW
- ↵$Corresponding author: Caroline Wright, University of Exeter Medical School, RILD building Level 4, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, E-mail: caroline.wright{at}exeter.ac.uk
↵* These authors contributed equally to this work
Posted November 11, 2019.
Assessing the analytical validity of SNP-chips for detecting very rare pathogenic variants: implications for direct-to-consumer genetic testing
